Compounds > n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea
Page last updated: 2024-09-03

n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea and Vomiting

n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea has been researched along with Vomiting in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chollet, P; Cure, H; D'Incan, M; Durando, X; Madelmont, JC; Mouret-Reynier, MA; Souteyrand, P; Thivat, E1

Trials

1 trial(s) available for n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea and Vomiting

ArticleYear
Second-line chemotherapy of disseminated malignant melanoma with cystemustine at 60 mg/m2: a phase II trial.
    Anti-cancer drugs, 2005, Volume: 16, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Female; Humans; Male; Melanoma; Middle Aged; Nausea; Neoplasm Metastasis; Neutropenia; Nitrosourea Compounds; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vomiting

2005